White Paper - 2024 Executive Pricing Survey

2024 Business Services Pricing Benchmarks

We analyzed the responses from our 2024 Executive Pricing Survey and uncovered actionable insights for companies in Pharmaceuticals across North America and Europe.

Executives in pharmaceuticals provided insider information on the price increases, gross margin, and revenue growth from 2023 and their targets for 2024. We analyzed their responses and uncovered several traits the high performing companies had in common. Discover those and other insights in our Pharmaceuticals Pricing Benchmarks white paper.

Some Key Insights:

  • North American Pharmaceutical companies had higher net price realization over European Pharmaceutical companies
  • Europe set higher price increase and revenue growth targets and realized greater growth
  • High discounting in both regions has led to net price underperformance versus inflation
  • Companies passing on less than 50% of costs attain ambitious growth targets while still realizing a significantly higher net price increase

Download the Report


About the Pricing Survey Methodology

Revenue Management Labs commissioned the pricing survey in late 2023 of 520 senior decision-makers, VP and C-Suite, and across more than 9 industries in North America and Europe. Pharmaceuticals was one of those industries and was evenly split between the two geographic regions. The respondents were required to be in companies with an annual revenue of over $100 million. All the respondents had verified knowledge of their company’s pricing strategy and financial performance.

Our questions covered past pricing and revenue performance from 2023 and the pricing and revenue targets for 2024. The questions were designed to benchmark pricing performance generally and across various industries. 

Pricing Benchmarks 2023

2023 Pricing Benchmarks

Understand how your price increases, discounts, and revenue compares to other companies' targets in Pharmaceuticals.

Pricing Benchmarks 2024

2024 Pricing Benchmarks

Compare your pricing targets to other Pharmaceutical companies in your region.

Pricing Strategy

Optimize your Pricing Strategy

Review and revise your pricing strategy using the best-in-class practices of high performing Pharmaceutical companies.

White Paper

This year’s instalment of the Executive Pricing Survey provides insider information on past pricing performance, revenue growth, and 2024 targets. You will receive actionable insights, learning how the highest performing companies drive results.

We provide specialized pricing strategy for companies in pharmaceuticals. Explore how we can drive revenue growth
and profitability for pharmaceuticals »

Additional Pricing White Papers

Speak with Us

We are here to help you achieve profitable revenue growth

Schedule a call

Webform - Schedule a call

a green and blue circle on a white background


Executive Pricing Survey Results

We will cover the full results from our 2024 Executive Pricing Survey. See how you compare to your competitors both in past performance and for 2024 pricing strategy.